RÉSUMÉ
Post-COVID-19 conditions (PCC) is an umbrella term that encompasses a range of signs, symptoms and conditions present weeks after the acute phase of a SARS-CoV-2 infection. This systematic literature review summarises the heterogeneous methodology used to measure PCC across real-world studies and highlights trends by region, age group, PCC follow-up period and data source. METHODS: Medline, EMBASE and the Cochrane Library were searched and supplemented with conference and grey literature searches. Eligible studies included individuals with (1) PCC or (2) a positive SARS-CoV-2 test or COVID-19 diagnosis who were followed over time. Included studies were published in English between 1 January 2020 and 14 November 2022. FINDINGS: Of 291 publications included, 175 (60%) followed individuals with confirmed COVID-19 over time for PCC and 116 (40%) used a prespecified PCC definition. There was substantial heterogeneity in study design, geography, age group, PCC conditions/symptoms assessed and their classification and duration of follow-up. Among studies using a prespecified PCC definition, author-defined criteria (51%) were more common than criteria recommended by major public health organisations (19%). Measurement periods for PCC outcomes from date of acute COVID-19 test were primarily 3 to <6 months (39.2%), followed by 6 to <12 months (27.5%) and <3 months (22.9%). When classified by organ/system, constitutional-related PCC were the most frequently assessed in adult (86%) and paediatric (87%) populations. Within constitutional symptoms, fatigue was most frequently assessed in adult (91.6%) and paediatric (95.0%) populations, followed by fever/chills (37.9% and 55%, respectively). CONCLUSIONS: PCC definitions are heterogenous across real-world studies, which limits reliable comparisons between studies. However, some similarities were observed in terms of the most frequently measured PCC-associated symptoms/conditions, which may aid clinical management of patients with PCC.CRD42022376111.
Sujet(s)
COVID-19 , Humains , Enfant , COVID-19/diagnostic , COVID-19/épidémiologie , SARS-CoV-2 , Dépistage de la COVID-19 , Syndrome de post-COVID-19RÉSUMÉ
OBJECTIVES: Understanding disease seasonality can help predict the occurrence of outbreaks and inform public health planning. Respiratory diseases typically follow seasonal patterns; however, knowledge regarding the seasonality of COVID-19 and its impact on the seasonality of influenza remains limited. The objective of this study was to provide more evidence to understand the circulation of SARS-CoV-2, the virus responsible for COVID-19, in an endemic scenario to guide potential preventive strategies. DESIGN: In this study, a descriptive analysis was undertaken to describe seasonality trends and/or overlap between COVID-19 and influenza in 12 low-income and middle-income countries using Our World in Data and FluMart data sources. Plots of COVID-19 and influenza cases were analysed. SETTING: Singapore, Thailand, Malaysia, the Philippines, Argentina, Brazil, Mexico, South Africa, Morocco, Bahrain, Qatar and Saudi Arabia. OUTCOME MEASURES: COVID-19 cases and influenza cases. RESULTS: No seasonal patterns of SARS-CoV-2 or SARS-CoV-2/influenza cocirculation were observed in most countries, even when considering the avian influenza pandemic period. CONCLUSIONS: These results can inform public health strategies. The lack of observed seasonal behaviour highlights the importance of maintaining year-round vaccination rather than implementing seasonal campaigns. Further research investigating the influence of climate conditions, social behaviour and year-round preventive measures could be fundamental for shaping appropriate policies related to COVID-19 and respiratory viral disease control in low-income and middle-income countries as COVID-19 variant data and epidemiologic patterns accrue over time.
Sujet(s)
COVID-19 , Grippe humaine , Humains , COVID-19/épidémiologie , Grippe humaine/épidémiologie , SARS-CoV-2 , Saisons , Amérique latine/épidémiologie , Pays en voie de développement , Moyen Orient , ThaïlandeRÉSUMÉ
Introduction: Epidemiological modeling is widely used to offer insights into the COVID-19 pandemic situation in Asia. We reviewed published computational (mathematical/simulation) models conducted in Asia that assessed impacts of pharmacological and non-pharmacological interventions against COVID-19 and their implications for vaccination strategy. Methods: A search of the PubMed database for peer-reviewed, published, and accessible articles in English was performed up to November 2022 to capture studies in Asian populations based on computational modeling of outcomes in the COVID-19 pandemic. Extracted data included model type (mechanistic compartmental/agent-based, statistical, both), intervention type (pharmacological, non-pharmacological), and procedures for parameterizing age. Findings are summarized with descriptive statistics and discussed in terms of the evolving COVID-19 situation. Results: The literature search identified 378 results, of which 59 met criteria for data extraction. China, Japan, and South Korea accounted for approximately half of studies, with fewer from South and South-East Asia. Mechanistic models were most common, either compartmental (61.0%), agent-based (1.7%), or combination (18.6%) models. Statistical modeling was applied less frequently (11.9%). Pharmacological interventions were examined in 59.3% of studies, and most considered vaccination, except one study of an antiviral treatment. Non-pharmacological interventions were also considered in 84.7% of studies. Infection, hospitalization, and mortality were outcomes in 91.5%, 30.5%, and 30.5% of studies, respectively. Approximately a third of studies accounted for age, including 10 that also examined mortality. Four of these studies emphasized benefits in terms of mortality from prioritizing older adults for vaccination under conditions of a limited supply; however, one study noted potential benefits to infection rates from early vaccination of younger adults. Few studies (5.1%) considered the impact of vaccination among children. Conclusion: Early in the COVID-19 pandemic, non-pharmacological interventions helped to mitigate the health burden of COVID-19; however, modeling indicates that high population coverage of effective vaccines will complement and reduce reliance on such interventions. Thus, increasing and maintaining immunity levels in populations through regular booster shots, particularly among at-risk and vulnerable groups, including older adults, might help to protect public health. Future modeling efforts should consider new vaccines and alternative therapies alongside an evolving virus in populations with varied vaccination histories.
Sujet(s)
COVID-19 , Vaccins , Enfant , Humains , Sujet âgé , COVID-19/épidémiologie , COVID-19/prévention et contrôle , Pandémies , Asie/épidémiologie , Vaccination , Simulation numériqueRÉSUMÉ
BACKGROUND: The coronavirus disease 2019 (COVID-19) pandemic has imposed significant burden on Brazil's health system. This study aimed to examine clinical characteristics, overall vaccine uptake, and to assess healthcare resource utilization (HCRU) and costs associated with acute COVID-19 in Brazil during the Omicron predominant period. METHODS: A nationwide retrospective study was conducted using various Brazilian databases including, COVID-19 related databases, public health systems, and other surveillance/demographic datasets. Individuals with positive COVID-19 test results between January 1 2022 and April 30 2022, during Omicron BA.1/BA.2 wave, were identified. Patients' demographics, vaccine uptake, HCRU and corresponding costs were described by age groups. RESULTS: A total of 8,160,715 (3.80%) COVID-19 cases were identified in the study cohort, ranging from 2.43% in <5 years to 62.05% in 19-49 years. The uptake of partial (Dose 1) or full immunization (Dose 2) was less than 0.1% in children aged <5 years, whereas in individuals ≥ 19 years, it exceeded 89.78% for Dose 1 and 84.07% for Dose 2. Overall booster vaccine uptake was 38.06%, which was significantly higher among individuals aged ≥ 65 years, surpassing 74.79%. Regardless of vaccination status, 87.2% cases were symptomatic, and 1.48% were hospitalized due to acute COVID-19 (<5 years: 2.33%, 5-11 years: 0.99%, 12-18 years: 0.32%, 19-49 years: 0.40%; 50-64 years: 1.50%, 65-74 years: 5.43%, and ≥ 75 years: 17.89%). Among the hospitalized patients (n = 120,450), 32.57% were admitted to ICU, of whom 31,283 (79.75%) individuals required mechanical ventilation (MV) support. The average cost per day in normal ward and ICU without MV in public/general hospital settings was $104.36 and $302.81, respectively. While average cost per day in normal ward and ICU with MV was $75.91 and $301.22 respectively. CONCLUSIONS: This study quantified the burden of COVID-19 in Brazil, suggesting substantial healthcare resources required to manage the COVID-19 pandemic.
Sujet(s)
COVID-19 , Vaccins , Enfant , Humains , Brésil/épidémiologie , COVID-19/épidémiologie , Pandémies , Études rétrospectivesRÉSUMÉ
OBJECTIVES: To determine the incidence, aetiology and pneumococcal serotype distribution of community-acquired pneumonia (CAP) in Brazilian adults during a 2-year period. DESIGN: Prospective population-based surveillance study. SETTING: Patients from two emergency hospitals in Brazil were consecutively included in this study. PARTICIPANTS: A total of 111 adults aged 50 years and older with radiographically-confirmed CAP requiring an emergency department visit were prospectively enrolled between January 2018 and January 2020. MAIN OUTCOME MEASURES: Incidence rates of CAP were calculated according to age and pathogen. Pathogens were identified by conventional microbiological methods. Additionally, a novel, Luminex-based serotype specific urinary antigen detection assay was used to detect serotypes included in pneumococcal vaccines. RESULTS: Mean age of participants was 64 years and 31% were aged ≥70 years. Aetiology was established in 61 (57%) patients; among identified cases, the most common pathogens were Streptococcus pneumoniae (42/61, 69%) and influenza (4/61, 7%). Among serotypes identified from the 42 cases of pneumococcal CAP, estimated coverage ranged by pneumococcal vaccine formulations from 47.6% (13-valent), 59.5% (20-valent, licenced in the USA only) and 71.4% (23-valent). In patients with CAP, 20-valent pneumococcal vaccine serotypes were identified 2.5 times more frequently than 10-valent pneumococcal vaccine serotypes (22.5% vs 9.0%). The incidence rate for CAP in adults aged ≥50 years was 20.1 per 10 000 person-years. In general, the incidence of CAP increased consistently with age, reaching 54.4 (95% CI 36.8 to -76.6) per 10 000 in adults 80 years or older. CONCLUSIONS: We observed a high burden of pneumococcal CAP among adults in Brazil. Despite the routine immunisation of children and high-risk adults against pneumococcal disease in the Brazilian national vaccination programme, a persistent burden of pneumococcal CAP caused by vaccine serotypes remains in this population.
Sujet(s)
Infections communautaires , Infections à pneumocoques , Pneumonie à pneumocoques , Adulte , Sujet âgé , Sujet âgé de 80 ans ou plus , Brésil/épidémiologie , Enfant , Infections communautaires/épidémiologie , Infections communautaires/microbiologie , Infections communautaires/prévention et contrôle , Humains , Incidence , Adulte d'âge moyen , Infections à pneumocoques/prévention et contrôle , Vaccins antipneumococciques , Pneumonie à pneumocoques/épidémiologie , Pneumonie à pneumocoques/prévention et contrôle , Études prospectives , Sérogroupe , Streptococcus pneumoniae , Vaccins conjugués , Observation (surveillance clinique)RÉSUMÉ
OBJECTIVES: The aim of this study was to evaluate the epidemiological profile of invasive meningococcal disease (IMD) in Brazil, the first Latin American country to introduce the group C meningococcal conjugate vaccine (included in the vaccination schedule in 2010). METHODS: A systematic review was conducted, covering the years 2005-2017, to identify epidemiological information on IMD and Neisseria meningitidis carriers in Brazil. Documents from the Brazilian Ministry of Health and two public databases were analyzed to determine annual incidence rates, absolute numbers of diagnosed cases, serogroups identified, the relative distribution of cases per serogroup, and the case fatality rate (CFR). RESULTS: Sixteen studies were selected. The incidence rate ranged from 0.88 to 5.3 cases per 100000 inhabitants per year. According to secondary data, the annual incidence of IMD in 2015 was highest in males <1year old (7.1/100000). The number of diagnosed cases declined significantly over the years. In the literature, IMD showed a CFR from 20.0% to 50.0%, and a higher CFR for serogroup W (17.8%). Secondary data showed an absolute reduction in meningitis-attributable deaths between 2007 and 2015; however, the CFR remained stable (11.1% in 2007 and 8.4% in 2015). In 2015, serogroup W showed the highest CFR (24.1%), followed by serogroups C (19.2%), B (17.7%), and Y (14.3%). CONCLUSIONS: Despite a reduction in cases, the CFR remained stable and similar in the different age groups, even for disease caused by different serogroups. The highest CFR was found to be associated with serogroup W.
Sujet(s)
Infections à méningocoques/épidémiologie , Infections à méningocoques/prévention et contrôle , Brésil/épidémiologie , Bases de données factuelles , Humains , Calendrier vaccinal , Incidence , Vaccins antiméningococciques/usage thérapeutique , Neisseria meningitidis/isolement et purification , SérogroupeRÉSUMÉ
Benign inclusions are foci of non-neoplastic ectopic tissue in lymph nodes. They are classified into three types: epithelial, nevomelanocytic and decidual. It is important to identify them for the differential diagnosis with lymph node metastases, particularly among patients who present proliferative benign lesions. In general, epithelial inclusions are presented inside lymph nodes as epithelial cysts or as numerous structures resembling ducts. The cells of these structures may originate from the cells of paramesonephricus ducts, salivary glands, breast tissue, thyroid follicles, squamous epithelium or mesothelium. Paramesonephricus -type inclusions are almost exclusively found in pelvic lymph nodes and, in appearance, they resemble the epithelium of the uterine tube. Inclusions of breast tissue are composed predominantly of ectopic mammary glands and ducts that present diverse morphological characteristics that still have obscure etiology. Thyroid-type inclusions are frequently found in cervical and axillary lymph nodes, and it is believed that, embryologically, they arise from the mixing of tissues from which lymph nodes and the thyroid gland originate. Mesothelial inclusions occur preferentially in the mediastinal lymph nodes of patients who are affected by pleural or pericardial effusions. Aggregates of melanocytic cells are generally found in the lymph node capsule. The explanation for this occurrence is uncertain, but it is believed to be a consequence of incorrect migration of neural crest cells, or because of "benign metastases" of nevi present in the skin. Studies on benign inclusions in lymph nodes take on importance through assisting in correctly diagnosing the presence of metastases.
Las inclusiones benignas son focos de tejido ectópico no neoplásico en los linfonodos. Ellos son clasificados en tres grupos: epitelial, nevomelanocítico y decidual. Es importante identificarlos para el diagnóstico diferencial con metástasis de linfonodos, particularmente en aquellos pacientes que presentan lesiones proliferativas benignas. En general, las inclusiones epiteliales se presentan dentro de los linfonodos como quistes epiteliales o como numerosas estructuras que parecen conductos. Las células de estas estructuras se pueden originar a partir de las células del conducto paramesonéfrico, glándulas salivales, tejido mamario, folículos tiroideos, epitelio escamoso o mesotelio. Las inclusiones tipo paramesonéfrico son exclusivamente encontradas en los linfonodos pélvicos y su apariencia recuerda el epitelio de la tuba uterina. Las inclusiones del tejido mamario están compuestas predominantemente de tejido mamario glandular ectópico y los ductos presentan diversas características morfológicas las que no tienen una clara etiología. Las inclusiones del tipo tiroideas son frecuentemente encontradas en los linfonodos cervicales y axilares y se cree que embriológicamene, se originan de una mezcla de tejidos de que origina linfonodos y tejido glandular tiroideo. Las inclusiones mesoteliales ocurren preferentemente en los linfonodos mediastínicos de pacientes que son afectados por dilataciones pleurales y pericárdicas. Los agregados de células melanocíticas son generalmente encontrados en la cápsula de los linfonodos. La explicación para este hecho es incierta, pero se cree que es una consecuencia incorrecta de la migración de células de la cresta neural o por metástasis benignas de nevos presentes en la piel. Los estudios de las inclusiones benignas en linfonodos toma importancia ya que a través de ellos se puede ayudar a un correcto diagnóstico de la presencia de metástasis.